Stocks Hitting 52-Week Highs
Vertex Pharmaceuticals (NASDAQ: VRTX) shares reached a new 52-week high of $95.02 after the company reported that its two phase 3 study of Lumacaftor in combination with ivacaftor met the primary endpoint.
IDEXX Laboratories (NASDAQ: IDXX) gained 2.19% to reach a new 52-week high of $135.53. Canaccord Genuity upgraded IDEXX from Hold to Buy and raised the price target from $116.00 to $148.00.
Intel (NASDAQ: INTC) shares rose 0.69% to touch a new 52-week high of $30.44. Intel's trailing-twelve-month revenue is $52.89 billion.
Yum! Brands (NYSE: YUM) shares gained 0.24% to touch a new 52-week high of $80.80. Yum's PEG ratio is 1.56.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.